In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Jonathan Dickinson, CEO and Co-Founder of Ambio Life Sciences, about the evolving role of ibogaine in psychedelic medicine.
Jonathan shares his path from leading the Global Ibogaine Therapy Alliance to helping build one of the field’s most prominent ibogaine treatment organizations. Together they explore ibogaine’s expanding therapeutic potential for traumatic brain injury, addiction, and neurological conditions, along with the clinical realities of delivering this powerful medicine safely.
They also discuss the challenges of scaling ibogaine treatment, the importance of preparation and integration, and how traditional Bwiti knowledge from Gabon continues to shape ethical and culturally grounded approaches to this work.
Jonathan Dickinson is the CEO and Co-Founder of Ambio Life Sciences and a leading expert on ibogaine therapy. With more than 15 years of experience in psychedelic research, clinical care, and traditional practice, he has helped shape global safety standards for ibogaine treatment.
A Mexico-licensed psychologist and former Executive Director of the Global Ibogaine Therapy Alliance, Jonathan has published research on ibogaine’s therapeutic potential for trauma, traumatic brain injury, and neurological conditions. He has also been initiated into the Bwiti traditions of Gabon and holds a Nagoya-compliant export license for Tabernanthe iboga root.
The Microdosing Practitioner Certification empowers you to launch a sustainable practice built on integrity, science, and results. Learn Paul F. Austin’s signature San Pedro Microdosing Protocol, master somatic coaching skills, and confidently guide clients toward lasting transformation. Click here to learn more and apply.
This episode is brought to you by The Practitioner Certification Program by Third Wave’s Psychedelic Coaching Institute. To learn more about our flagship 6-month training program for coaches who want to integrate psychedelic modalities into their practice, click here.